Peter Rudd-Clarke specialises in the life sciences and consumer products sectors. He advises on the regulation of medical devices, CE marking, clinical trials, consumer products and ongoing compliance matters. The litigation and risk management side to his practice sees Peter defending manufacturers of complex products, often across multiple jurisdictions.Peter presents and writes articles on issues such as artificial intelligence, supply chains, cross-border litigation, medical device regulations and Brexit. His articles have been published in publications such as Insurance Day, Post Magazine and Insider Quarterly and he has been quoted in the Times and insurance press discussing risk management issues.

Issaq Ahmed is a Consultant Orthopaedic Surgeon based in Edinburgh. His active interests include enhanced recovery following robotic hip and knee replacement surgery.

Mr Jim Adshead qualified at Cambridge University and moved into a London training scheme. He completed a six year training programme in urology in the West London teaching hospitals and gained valuable experience in urological cancer and minimally invasive access during a laparoscopic fellowship year in Sydney, Australia. Currently appointed as a Consultant at The Lister Hospital, Stevenage for 10 years. Jim has produced national guidelines in consenting for urological surgery.

Alan is a qualified Management Accountant and an Honorary Professor in Intelligent Systems at UCL with over 25 years of experience as a technology leader in Healthcare, Financial Services and as a successful ‘technopreneur’. He has worked on 4 continents with knowledge of globalisation in local health systems, leveraging latest generation Cloud technologies with a passionate purpose to improve health outcomes at scale. Prior to this role, he ran his own company advising Healthcare policy institutions, 13485 regulated medical device and AI Healthcare companies. As a CIO he has also led global technology divisions for Aetna International, Nuffield Health, JPMorganChase, Merrill Lynch and AIG.

Mr Bolger is founder and co-owner of My iClinic, an independent eye hospital in London. He resigned his NHS consultant post in 1994 and has worked independently ever since. He is invited to lecture extensively both in Britain and abroad, and his surgery master classes are very highly rated. “I feel I would regard myself as an “early adopter”. First intraocular lens implants, then phacoemulsification and now, Smile. Small Incision Lenticule Extraction. I am very lucky that I entered ophthalmology just when it was about to undergo a series of revolutionary advances.

Chris Coulson is a ENT consultant at the Queen Elizabeth hospital, Birmingham. His fields of interest are endoscopic ear surgery, stapes surgery and cochlear implantation. He has a PhD in robotic surgery. He is the CEO of endoscope-i, a tech start-up company creating and delivering innovative healthcare solutions.

Prof. Ernst is a German cardiac electrophysiologist with a special expertise in complex arrhythmias such as atrial fibrillation and ventricular arrhythmia both in paediatric and adult patients. She works at the Royal Brompton Hospital in London and is a Professor of Practice (Cardiology) at the National Heart and Lung Institute of Imperial College. She is one of the pioneers of remote magnetic navigation and has established this technique from its’ initiation to clinical routine using state of the art equipment including advanced 3D mapping techniques. Image integration from 3D acquisitions from magnetic resonance imaging or computed tomography assist her in performing her interventions.

Jaquie is Head of Digital Health at Cambridge Consultants and leads the initiative to provide strategic guidance and technical solutions for clients transitioning their business model to include a digital element. These digital elements include device connectivity, AI, security, launch strategies, behavioural science and digital service design. Jaquie has previously worked on the design and launch of a compliance & work management IoT service that is in commercial use. She has a BSc in Applied Biology, 10 years’ experience in Molecular Biology and 15 years’ experience of Product Management and Marketing for software, hardware and digital services in medical and life science industries that include immunology, ophthalmology, neuroscience and bioinformatics. Jaquie is a member of the Chartered Institute of Marketing (CIM).

Dr Grootendorst has 10 years of experience in clinical research and development at Lightpoint Medical, Guy’s & St Thomas’ Hospital, London and Medisch Spectrum Twente, Netherlands. He has multiple publications on novel technologies for intraoperative cancer detection. He has a PhD from King’s College, London.

Matthew leads the Deloitte Artificial Intelligence Studio team based in the UK, working cross industry to help clients understand and deliver the opportunities of rapidly evolving advanced data science and automation technologies and move from hype to real use cases and implementation. Matt has extensive experience of working in advanced healthcare technologies, recent experience includes design and deployment of automated patient referrals triage using AI, deployment of chatbots to support shared services and the use of AI to automate patient data processing. He has also worked with international governments on the application of AI and other emerging technologies for the improvement of policy development and provision of public services. His background includes academic research, start-up biotech, Big Pharma, IBM, and Deloitte Innovation. Prior to Deloitte he was the European Head of Watson Health, working with both pharmaceutical and healthcare organizations. Matthew is a member of the All Party Parliamentary Group on Artificial Intelligence (www.appg-ai.org).

Saurabh leads the AI research team at Babylon. He has been with Babylon since 2016. In this time he has guided the team to develop Babylon’s AI for the development of the triage, diagnostic and predictive models for healthcare, and applied the team’s research in Bayesian Machine Learning and Causal inference. Prior to Babylon, Saurabh spent time as a post-doctoral researcher at the MRC Centre for Outbreak Analysis & Modelling at Imperial College London. This work was funded by the Gates Foundation in collaboration with the CDC, and focused on the development of novel statistical machine learning methods to estimate poliovirus transmission from genetic sequence data. Before his post-doctoral work, Saurabh completed his PhD in population genetics from Imperial College London, investigating the population genetics of Tuberculosis and predicting new drug targets from whole genome sequence data.

Emma is an Associate Solicitor at RPC, specialising in Medical/Life Sciences and Product Liability. She acts on a range of cases and represents insurers, private healthcare providers, healthcare practitioners and manufacturers of medical devices and pharmaceutical products in the defence of medical malpractice and product liability claims and in relation to clinical trials. She also represents healthcare organisations and practitioners at inquests, and advises on clinical governance issues, regulatory requirements, indemnity and coverage.

James Kinross is a Senior Lecturer in Surgery at Imperial College London. He performs robotic surgery for colorectal cancer. His group is developing smart sensing surgical instruments based on machine learning of chemical data used during surgery.

Dr. Christopher Kelly is a clinician scientist working in Google Health’s artificial intelligence imaging and diagnostics team. He focuses on the safe translation of Google’s artificial intelligence research into real clinical impact. Prior to joining Google, he completed a PhD in medical imaging at King’s College London. As a clinician, he created an award-winning smartphone app called NeoMate, used worldwide to support doctors and nurses looking after sick newborn infants. He continues to practise as a paediatrician on the neonatal intensive care unit at St Thomas’ Hospital, London. Alongside medicine, Chris previously founded and sold two internet companies and is an active angel investor in technology startups.

Yvonne W. Lui, MD is Associate Professor and Associate Chair for Artificial Intelligence in the Department of Radiology at NYU Grossman School of Medicine and the Vilcek Institute of Graduate Biomedical Sciences. The program she leads leverages technological advances in machine learning for medical imaging. She serves as the collaboration lead on major AI research partnerships with both academia and industry including NYU Courant Institute and Center for Data Science, Siemens Healthineers, and Facebook AI Research. Dr. Lui is a NIH-funded researcher in translational neuroimaging to study traumatic brain injury. She serves on NIH scientific review committees, is a member of the Standard Setting Committee and is a member of the board of directors of the American Society of Neuroradiology (ASNR), and Senior Editor for the American Journal of Neuroradiology (AJNR).

Brent Mittelstadt is a Research Fellow and British Academy Postdoctoral Fellow in data ethics at the Oxford Internet Institute, a Turing Fellow at the Alan Turing Institute, and a member of the UK National Statistician’s Data Ethics Advisory Committee. He is a philosopher and data ethicist with a particular focus on the ethical governance of complex algorithmic systems including machine learning, artificial intelligence, predictive analytics, Big Data, and medical expert systems.

Dr Rizwan Malik is a leading radiologist with an interest in health tech, digital imaging, and the potential of AI to support clinicians and patients. Rizwan studied medicine in Cambridge and London before qualifying as a radiologist. He joined what is now Bolton NHS Foundation Trust in 2006 and has held a number of increasingly senior roles at the organisation, where he became divisional medical director in 2020. Alongside his career in radiology, he has been a clinical advisor to leading imaging suppliers, and is managing director of South Manchester Radiology, a consultancy that advises the NHS and vendors on transformation and innovation, with a focus on imaging and AI.

Rizwan was instrumental in helping Bolton NHS Foundation Trust to introduce AI for chest x-rays, to help doctors identify deteriorating and improving Covid-19 patients. The project won the HealthTechToShoutAbout award in the Health Tech Awards 2020 as well as the AI in Medicine Best COVID-19 AI Solution 2020.

Rizwan says his priority is to see healthcare make similar gains in the future. “Both the healthcare system and its suppliers need to be asking: how can we go further?” he says.

Prof Mahmoud Hafez is a pioneer in patient-specific instrument (PSI) technology (3D planning & printing for joint replacement). He was initially involved in developing a robot for knee surgery in 1998, with a team of surgeons, engineers and computer scientists from Hull, Dundee, and Loughborough Universities, UK. During his SpR training, he started an MD project at Leeds University in 2001 resulted in developing the novel PSI technique. He learned the theory and practice of navigation, AI, robotics, simulation and VR during his CAOS fellowship in Pittsburgh and Toronto (2004-2006). Currently, he is a Prof & head of the orthopaedic Dept, October 6 University, Cairo. In Egypt, he founded an R&D lab and filed 20 patents for the use of PSI in arthroplasty, tumours, trauma, deformities and infection. Now, he is using PSI routinely for complex and bilateral knee replacement in a cost-effective manner.

Dr Rayna Patel is a medical doctor & neuroscientist (Cambridge, Harvard, MIT, Columbia) with an MPhil in Translational Medicine funded by GSK. She has extensive experience in academia and was a Post-Doctoral Fellow of Clare Hall College, Cambridge. Rayna has subsequently held strategic & commercial roles in government policy, tech startups & the Cabinet Office’s Nudge Unit, where she used behavioural science to rewire patient behaviours through digital products. She is currently CEO and Co-Founder of Vine Health, a digital platform using a combination of behavioural science and AI to improve the quality of life and survival of cancer patients, whilst generating crucial real-world data to better inform healthcare delivery and drug development.

Dr. Michael Persky is an Otolaryngologist - Head & Neck Surgeon at the NYU Grossman School of Medicine in New York City. As the Director of Head & Neck Robotic Surgery, Dr. Persky focuses on the utility of robotic surgery in treating patients with head and neck cancer. He has talked nationally and internationally on the subject and is focused on advancing the field as technology forges ahead.

Danny is the AI Clinical Lead at the Guy’s Cancer Centre, and a co-director for the newly established Guy’s Cancer AI Clinical Evaluation Unit, a joint venture between the Cancer Centre and the NICE funded King’s Technology Evaluation Centre (KiTEC) at King’s College London.  The aim of the unit is to develop and apply an AI validation framework, evidence standards and methods to the clinical evaluation of AI technology in cancer care.

Danny has formerly held posts as Director of Public health for the London Borough of Lewisham and the City of Newcastle, and as Senior Lecturer in Epidemiology and Health Services Research at Newcastle University and Dundee University. Danny has developed national clinical guidelines for the NHS in Scotland, conducted large randomised trials, and developed Patient Reported Outcome measures recommended by the US FDA, used with patients across the NHS in England and throughout the world.

One of Europe’s leading robotic thoracic surgeons with a strong interest in surgical robotics as a part of multi-disciplinary cancer treatments.

Dr. Edwin Rajadurai is the Managing Director of Servca. Servca is an independent international specialist Lloyd’s Broker specialising in professional, financial, and medical indemnity insurance and risk management. Having qualified as a medical doctor in 2011, Edwin can apply his clinical knowledge to offer a medical perspective when dealing with underwriters, clients, and stakeholders alike. Edwin expanded the international healthcare liability division, which encompasses Medical Malpractice, Life Sciences & Pharmaceuticals risks throughout the UK, Europe, USA, and Canada. His priority is to provide bespoke advice and support to brokers and their doctor clients on medical malpractice and ensure doctors receive the best policy tailored to them. Servca’s specialist wordings and unique in-house medical knowledge offer comprehensive support to all clients with an educational and personal touch. His commitment, enthusiasm, and innovative approach in assisting medical practitioners and underwriters give him kudos in the London and Lloyd’s market.

Paul is a solicitor and partner at Enable Law based in Bristol. He specialises in clinical negligence, acting for patients. He has a particular interest in claims involving adults with brain injuries, amputations, sepsis and the delayed diagnosis of cancer. He lectures and publishes articles regularly on medico-legal issues and has spoken on radio and television. He is involved in training medical experts and giving core training on legal issues to medical professionals. He is recognised as a leader in the field by the independent legal directories Chambers and Legal 500.

Vinidh is a Consultant Head and Neck Surgeon at The Royal Marsden Hospitals and Professor of Robotic and Endoscopic Head and Neck Surgery at the Institute of Cancer Research, London. He has expertise in Transoral Robotic Surgery and Transoral Laser Microsurgery for head and neck cancers. He has pioneered a new robotic technique to remove radiorecurrent and radioresidual cancers and is the first surgeon in the UK to perform robotic free flap reconstructions. He is the primary or co-recipient for over £3 million in grant funding, has published over 170 papers, and co-edited the fourth and fifth editions of the UK National Head and Neck Cancer Multidisciplinary Management Guidelines. He has also edited the volume on “Head and Neck Disease” for the 8th edition of Scott-Brown’s Otolaryngology, the leading multi-volume multi-author textbook in the specialty in the world. He is also chief editor for the forthcoming 6th edition of Stell & Maran’s Textbook of Head and Neck Surgery and Oncology.

Dr. Weiss is the Director of Ventricular Arrhythmia Management and Robotics at Banner University of Arizona Medical Center in Phoenix Arizona. He went to Medical school at the University of Virginia School of Medicine, Residency at University of Washington in Seattle, and did his fellowships in Cardiovascular Disease and Electrophysiology at Stanford University Medical Center and the University of Pennsylvania. Dr. Weiss has performed more than 1000 robotic procedures and has travelled around the world sharing his knowledge and expertise on RMN (Robotic Magnetic Navigation) with other physicians. He is also on the board of the Society for Cardiac Robotic Navigation. Since September he has been building the robotic EP program at Banner University with the recently installed Genesis RMN System.